BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
BIOR
Delisted
BIOR was delisted on the 10th of December, 2024.
42 hedge funds and large institutions have $8.72M invested in Biora Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
64% less capital invested
Capital invested by funds: $24.1M → $8.72M (-$15.4M)
Holders
42
Holding in Top 10
1
Calls
$226K
Puts
$60K
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.1M | |
| 3 | +$168K | |
| 4 |
Millennium Management
New York
|
+$122K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.7K |
Top Sellers
| 1 | -$3.17M | |
| 2 | -$36K | |
| 3 | -$34.7K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$24.9K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$22K |